A highly sensitive spectrofluorometric method for the determination of a new antidepressant drug, reboxetine, in tabletsÖNAL, Armagan.Journal of AOAC International. 2006, Vol 89, Num 4, pp 972-975, issn 1060-3271, 4 p.Article

A selective high-performance liquid chromatography method for the determination of reboxetine in bulk drug and tabletsÖNAL, Armagan; SAGIRI, Olcay; MÜGE CETIN, S et al.Journal of AOAC International. 2006, Vol 89, Num 6, pp 1552-1556, issn 1060-3271, 5 p.Article

Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levelsBARBON, Alessandro; CARACCIOLO, Luca; RACAGNI, Giorgio et al.Neurochemistry international. 2011, Vol 59, Num 6, pp 896-905, issn 0197-0186, 10 p.Article

Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imagingSEKAR, Sakthivel; VAN AUDEKERKE, J; VANHOUTTE, G et al.Psychopharmacologia. 2011, Vol 217, Num 4, pp 549-557, issn 0033-3158, 9 p.Article

Basal prolactin values correlate with response to reboxetine treatment in major depression, but not with response to citalopramMOELLER, Olaf; HETZEL, Guenter; MICHAEL, Nikolaus et al.Neuropsychobiology. 2005, Vol 51, Num 2, pp 67-71, issn 0302-282X, 5 p.Article

Reboxetine adjunct for partial or nonresponders to antidepressant treatmentRUBIO, Gabriel; SAN, Luis; LOPEZ-MUNOZ, Francisco et al.Journal of affective disorders. 2004, Vol 81, Num 1, pp 67-72, issn 0165-0327, 6 p.Article

Estimation of binding rate constants using a simultaneous mixed-effects method: application to monoamine transporter reuptake inhibitor reboxetineBENSON, Neil; SNELDER, Nelleke; PLOEGER, Bart et al.British journal of pharmacology. 2010, Vol 160, Num 2, pp 389-398, issn 0007-1188, 10 p.Article

Noradrenergic stimulation and motor performance : Differential effects of reboxetine on movement kinematics and visuomotor abilities in healthy human subjectsWANG, Ling E; FINK, Gereon R; DAFOTAKIS, Manuel et al.Neuropsychologia. 2009, Vol 47, Num 5, pp 1302-1312, issn 0028-3932, 11 p.Article

Does the clinical course of depression determine improvement in symptoms and quality of life?MOSES, Tally; LEUCHTER, Andrew F; COOK, Ian et al.The Journal of nervous and mental disease. 2006, Vol 194, Num 4, pp 241-248, issn 0022-3018, 8 p.Article

Monotherapy with reboxetine in amphetamine withdrawal syndromeDE DIOS MOLINA, Juan; DE PABLO, Silvia; LOPEZ-MUNOZ, Francisco et al.Progress in neuro-psychopharmacology & biological psychiatry. 2006, Vol 30, Num 7, pp 1353-1355, issn 0278-5846, 3 p.Article

Profound weight loss associated with reboxetine use in a 44-year-old womanLU, T. Y.-T; KUPA, A; EASTERBROOK, G et al.British journal of clinical pharmacology. 2005, Vol 60, Num 2, pp 218-220, issn 0306-5251, 3 p.Article

Catalyst-Controlled Diastereoselection in the Hydrogenation of Heterocycloalkyl KetonesAKASHI, Masaya; ARAI, Noriyoshi; INOUE, Tsutomu et al.Advanced synthesis & catalysis (Print). 2011, Vol 353, Num 11-12, pp 1955-1960, issn 1615-4150, 6 p.Article

Transfer of reboxetine into breastmilk, its plasma concentrations and lack of adverse effects in the breastfed infantHACKETT, L. Peter; ILETT, Kenneth F; RAMPONO, Jonathan et al.European journal of clinical pharmacology. 2006, Vol 62, Num 8, pp 633-638, issn 0031-6970, 6 p.Article

Clinically relevant doses of fluoxetine and reboxetine induce changes in the TrkB content of central excitatory synapsesWYNEKEN, Ursula; SANDOVAL, Mauricio; SANDOVAL, Soledad et al.Neuropsychopharmacology (New York, NY). 2006, Vol 31, Num 11, pp 2415-2423, issn 0893-133X, 9 p.Article

Use of reboxetine in bulimia nervosa: a pilot studyFASSINO, Secondo; DAGA, Giovanni Abbate; BOGGIO, Sonia et al.Journal of psychopharmacology (Oxford). 2004, Vol 18, Num 3, pp 423-428, issn 0269-8811, 6 p.Article

Decision making in humans: the effect of manipulating the central noradrenergic systemO'CARROLL, R. E; PAPPS, B. P.Journal of neurology, neurosurgery and psychiatry. 2003, Vol 74, Num 3, pp 376-378, issn 0022-3050, 3 p.Article

De nouveaux antidépresseurs sur le marché = The new antidepressant agentSCHAAD, N.Médecine et hygiène. 2001, Vol 59, Num 2372, pp 2497-2500, issn 0025-6749Article

Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: A pooled analysisPJREK, Edda; KONSTANTINIDIS, Anastasios; ASSEM-HILGER, Eva et al.Journal of psychiatric research. 2009, Vol 43, Num 8, pp 792-797, issn 0022-3956, 6 p.Article

Acute norepinephrine reuptake inhibition decreases performance in normal and high ambient temperatureROELANDS, Bart; GOEKINT, Maaike; HEYMAN, Elsa et al.Journal of applied physiology (1985). 2008, Vol 105, Num 1, pp 206-212, issn 8750-7587, 7 p.Article

Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetineBERLANGA, Carlos; FLORES-RAMOS, Monica.Journal of affective disorders. 2006, Vol 95, Num 1-3, pp 119-123, issn 0165-0327, 5 p.Article

Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferretWARNECK, Julie B; CHENG, Frankie H. M; RUDD, John A et al.Toxicology and applied pharmacology. 2008, Vol 232, Num 3, pp 369-375, issn 0041-008X, 7 p.Article

Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular dopamine in the frontal cortex of freely moving ratsOWEN, Jenny C. E; WHITTON, Peter S.Brain research. 2006, Vol 1117, pp 206-212, issn 0006-8993, 7 p.Article

Effects of reboxetine on sleep and nocturnal cardiac autonomic activity in patients with dysthymiaFERINI-STRAMBI, Luigi; MANCONI, Mauro; CASTRONOVO, Vincenza et al.Journal of psychopharmacology (Oxford). 2004, Vol 18, Num 3, pp 417-422, issn 0269-8811, 6 p.Article

Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patientsFERGUSON, James M; WESNES, Keith A; SCHWARTZ, Gerri E et al.International clinical psychopharmacology. 2003, Vol 18, Num 1, pp 9-14, issn 0268-1315, 6 p.Article

Effects of adjunctive reboxetine in patients with duloxetine-resistant depression: a 12-week prospective studySEGUI, J; LOPEZ-MUNOZ, F; ALAMO, C et al.Journal of psychopharmacology (Oxford). 2010, Vol 24, Num 8, pp 1201-1207, issn 0269-8811, 7 p.Article